Cadence™ Single-Use Inline Concentrator BrochureSource: Pall Life Sciences - BioPharmaceuticals
Single-pass tangential flow filtration (TFF) is revolutionizing how TFF is implemented in biotech, vaccine, blood plasma and other applications. Pall is now making it even easier to implement this breakthrough patented technology into your process. As with the original Cadence single-pass TFF module, the new Cadence Single-Use Inline Concentrator allows direct flow-through in process volume reduction and can be implemented into an existing process system or operate as a stand alone unit.
This exciting new technology leads to economic and practical benefits, including:
- Potential reduction of product damage or aggregation due to reduced residence time and shear exposure.
- Ability to couple the concentration of product before or after other downstream process steps, consequently optimizing other steps and reducing in-process pool tank volumes.
- Elimination of cleaning requirements.
- Easy integration of the assembled module, allowing plug and play.